Market Overview

Athersys Prices 19.8M Shares at $1.01

Related ATHX
Athersys' MultiStem Promotes Recovery After Acute Spinal Cord Injury in Preclinical Study
Athersys, Chugai End License Agreement For Exclusive Development, Commercialization of Multistem Cell Therapy for Ischemic Stroke in Japan

Athersys, Inc. (Nasdaq: ATHX) announced today that it has priced its offering of common stock. The Company has agreed to sell 19,802,000 shares of common stock through an underwritten public offering at $1.01 per share, which was the closing price of its common stock on October 25, 2012. In connection with the offering, the underwriters have been granted an over-allotment option to purchase an additional 2,970,300 shares of common stock. Both existing investors and new investors are participating in the offering.

Posted-In: News Offerings


Related Articles (ATHX)

View Comments and Join the Discussion!

Get Benzinga's Newsletters